International Clinical Trial: A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2011250040) titled 'A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease' on Oct. 8.

Study Type: Interventional

Study Design: randomized controlled trial, double blind, placebo control, parallel assignment, treatment purpose

Primary Sponsor: Ageishi Yuji

Condition: Chronic Obstructive Pulmonary Disease (COPD)

Intervention: Intervention name: AZD6793 Description: AZD6793 administered oraly throughout the study.

Intervention Na...